Indexed in PubMed/MEDLINE
Advances in vascular intervention and diagnostics require information to be at the fingertips of the vascular surgeon. Each issue of Vascular and Endovascular Surgery (VES) brings together the most recent peer-reviewed information to guide vascular specialists in endovascular, surgical, and medical treatment of vascular disease. Published six times a year, VES offers original scientific articles on vascular intervention, including the new endovascular therapies for peripheral artery, aneurysm, carotid, and venous conditions; as well as special interest topics presented in the format of Case Reports, Clinical Controversy discussions of disputed issues, comprehensive Basic Science reviews, an Endovascular Techniques section, and a Vascular Medicine section. Vascular and Endovascular Surgery addresses the spectrum of arterial, venous, and lymphatic disease and provides factual information that will expand your clinical perspective and treatment skills. The multidisciplinary approach to the vascular patient is emphasized with options of open surgical repair, endovascular intervention, and medical therapy discussed in each issue.
The Editorial Board, composed of well-known, respected academic vascular surgeons from all over the world is committed to providing timely, provocative articles that are relevant to enhancing the vascular care provided by the vascular surgeon in practice or in a resident-training program.
Topics presented in recent VES issues include:
- Endovascular Aortic Aneurysm Repair and Stent Technology
- Outcomes of Endovascular AAA Repair with Hostile Neck Anatomy
- Current Management of Carotid Artery Disease
- Protected Carotid Artery Stenting and Angioplasty
- Endovascular Therapy of Innominate-Subclavian Arterial Occlusive Lesions
- Aortic Graft Infection
- Peripheral Arterial Embolism
- Laser Atherectomy for Lower Extremity Revascularization
- Dialysis Access Patency and Repair with Stent-angioplasty
- Duplex Arteriography in the Evaluation of Acute Limb Ischemia
- Can CT Scans Predict Impending AAA Rupture
- Comparison of CT and Catheter Angiography for Evaluation of Peripheral Arterial Disease
- Inferior Vena Cava Filter Placement in Late-stage Cancer
- Platelet Function and Pharmacologic Inhibition
- Matrix Metalloproteinases in the Pathogenesis and Treatment of Aortic Aneurysm
- Hypertension and the Vascular Patient
- Angiogenesis, Vasculogenesis, and Induction of Healing in Chronic Wounds
This journal is a member of the Committee on Publication Ethics (COPE)
Vascular and Endovascular Surgery (VES) is a peer-reviewed, leading journal in its field devoted exclusively to all aspects of cerebrovascular and cardiovascular, peripheral vascular, and endovascular surgery. It reports the latest progress in operative surgical techniques together with new research findings, new clinical experiences, and new developments in diagnostic procedures.
|Thomas Maldonado, M.D. FACS||NYU School of Medicine, New York, USA|
|Ignacio Escotto Sánchez||National Autonomous University of Mexico, Mexico|
|Juan Varela||Clinica Universitaria Colombia, Bogotá, Colombia|
|Enrico Ascher||Maimonides Medical Center, USA|
|Keith D. Calligaro||Pennsylvania Hospital, USA|
|Kim J. Hodgson||USA|
|Alan B. Lumsden||Houston, TX, USA|
|Gregory L. Moneta, MD||Oregon Health and Science University; Knight Cardiovascular Institute, Portland, OR, USA|
|Gregorio A. Sicard||Barnes-Jewish Hospital, USA|
|Samuel S. Ahn||USA|
|Zak Arthurs||Sam Antonio Military Medical Center, San Antonio, TX, USA|
|Robert G. Atnip||Hershey Medical Center, USA|
|Martin A. Back||Tampa, FL, USA|
|Jeffrey L. Ballard|
|Carlos Bechara||Houston Methodist Hospital System, Houston, TX, USA|
|Michael Belkin||Brigham & Women's Hospital, USA|
|John J. Bergan|
|John Blebea, MD, MBA||Tulsa, OK, USA|
|Richard P. Cambria||Massachusetts General Hospital, USA|
|Jeffrey Carpenter||Hospital of the University of Pennsylvania, USA|
|Timothy A. Chuter||University of California, San Francisco, USA|
|G. Patrick Clagett||University of Texas Southwestern Medical Center, USA|
|Anthony J. Comerota||USA|
|Michael S. Conte||University of California, San Francisco, USA|
|John D. Corson|
|Frank J. Criado||Union Memorial Hospital, Baltimore, USA|
|Michael Dalsing||Indiana University School of Medicine, USA|
|Clement R. Darling||Albany Medical College, USA|
|David L. Dawson|
|Ralph G. De Palma||Department of Veteran's Affairs, USA|
|Tina R. Desai||The University of Chicago, USA|
|John F. Eidt||Baylor Heart and Vascular Hospital, USA|
|Bo G. Eklof||Sweden|
|Peter Faries||Baylor Heart and Vascular Hospital, USA|
|Mark F. Fillinger||USA|
|William R. Flinn||USA|
|Thomas L. Forbes||University of Toronto, Canada|
|Julie A. Freischlag||John Hopkins Medical Institutions, USA|
|Paul A. Gagne||New York University, Italy|
|Vivian Gahtan||SUNY Upstate Medical University, USA|
|Jerry Goldstone, MD||USA|
|Richard M. Green, MD||USA|
|Raul J. Guzman|
|Kakra Hughes, MD, FACS||Howard University and Hospital, Washington DC, USA|
|Glenn Jacobowitz||NYU Langone Medical Center, New York, NY, USA|
|Peter G. Kalman, MD||Independent Consultant, Canada|
|Timothy F. Kresowik||University of Iowa Health Care, USA|
|Brajesh K. Lal||New Jersey Medical School, USA|
|Stephen G. Lalka, MD||The Sanger Clinic, North Carolina, USA|
|W. Anthony Lee, MD||Boca Raton, FL, USA|
|Peter H. Lin||Houston, TX, USA|
|Fred N. Littooy||Loyola University Medical Center, Maywood, IL, USA|
|Joann M. Lohr||Lohr Surgical Specialists|
|Michael S. Makaroun||UPMC Heart and Vascular Institute, UK|
|William A. Marston||University of North Carolina, USA|
|Jon S. Matsumura||USA|
|George H. Meier, III||Brambleton Medical Center, USA|
|James O. Menzoian||USA|
|Joseph L. Mills||Arizona Health Sciences Center, USA|
|Samuel R. Money||Ochsner Clinic, New Orleans, LA, USA|
|Raghu L. Motaganahalli, MD, RPVI, FRCS, FACS||Indiana University School of Medicine, Indianapolis, IN, USA|
|Takao Ohki||Montefiore Medical Center/Albert Einstein School of Medicine, NY, USA|
|W. Andrew Oldenburg||Mayo Clinic, Minnesota, USA|
|Kenneth Ouriel, MD||Syntactx, USA|
|Jean M. Panneton||Vascular and Transplant Specialists, USA|
|Juan R. Parodi, MD||University of Buenos Aires, Argentina|
|Bruce A. Perler||USA|
|Luis A. Queral|
|John J. Ricotta||USA|
|John J. Rosenthal||Long Beach Surgical Group, USA|
|Mikel Sadek||NYU Langone Medical Center and Bellevue Hospital, New York, NY, USA|
|Hazim J. Safi||University of Texas-Houston Medical Center, USA|
|Russell H. Samson||Mote Vascular Foundation, USA|
|Luis A. Sanchez||Washington University School of Medicine, USA|
|Gary R. Seabrook||Medical College of Wisconsin, USA|
|Gregor D. Shanik||Ireland|
|Michael B. Silva, Jr.||The University of Texas Medical Branch, USA|
|Scott L. Stevens||University of Tennessee Medical Center, USA|
|Timothy M. Sullivan||Mayo Clinic, Minnesota, USA|
|Spence M. Taylor|
|William D. Turnipseed||University of Wisconsin Clinical Sciences, USA|
|Rodney A. White||Long Beach, CA, USA|
|Christopher K. Zarins||Stanford University, USA|
|R. Eugene Zierler||University of Washington, Seattle, WA, USA|
This journal is a member of the Committee on Publication Ethics (COPE)
Instructions for Authors
Vascular and Endovascular Surgery publishes peer-reviewed original articles and case reports relating to any phase of vascular diseases, including diagnostic methods, therapeutic procedures, operative techniques, clinical and laboratory research.
Manuscripts should be submitted electronically to http://mc.manuscriptcentral.com/ves where authors will be required to set up an online account on the SageTrack system powered by ScholarOne. Submissions must include a cover letter, a Word file with the text of the article, and separate files for each figure.
The manuscript is to be accompanied by a cover letter which states: (1) all the authors have read and approved the final manuscript; (2) the full name, address, phone and fax number, and e-mail address of the individual to whom correspondence concerning the manuscript is to be sent.
Manuscripts should be prepared using the AMA Style Guide (10th Edition).
Single space is required within the abstract, notes, titles and headings, block quotes, tables and figures, and references, etc. Double space is required before and after each single spaced block.
Page Numbers. All the pages must be numbered sequentially.
The manuscript should include four major sections (in this order): Title Page, Abstract, Main Body, and References.
Sections in a manuscript may include the following (in this order): (1) Title page, (2) Abstract, (3) Keywords, (4) Text, (5) References, (6) Tables, (7) Figures, and (8) Appendices.
1. Title page. Please include the following:
- Full article title
- Acknowledgments and credits
- Each author’s complete name, academic degrees, and institutional affiliation(s)
- Grant numbers and/or funding information
- Corresponding author (name, address, phone/fax, e-mail)
2. Abstract. Abstracts should be structured for reports of original data, systematic reviews (including meta-analyses), and clinical reviews (word limit should be 250-300 words).
Type the abstract on a separate page headed by the full article title. Omit author(s)’s names.
Abstracts are not required for special features such as letters, news articles, editorial etc.
3. Keywords. A short list of keywords should be given at the end of the abstract.
4. Text. Begin article text on a new page headed by the full article title.
Centered / Flush Left
Upper lower case, bold
First Level Heading
Upper lower case, bold
Second Level Heading
Upper lower case, italics
Third Level Heading
Upper lower case, italics, end with a dot and run-on with the next para
References: In-text citation.
For each text citation there must be a corresponding reference in the reference list and for each reference there must be a corresponding text citation.
Cite references in consecutive order using superscript Arabic numbers.
Each superscript must match one reference in the References list.
Use commas to separate multiple citation numbers in text. Corresponding references should be listed in numeric order at the end of the document. Unpublished works and personal communications (oral, written, and electronic) should be cited parenthetically (and not on the reference list). Superscript numbers are placed outside periods and commas, and inside colons and semicolons.
For citation examples please check AMA (10th Ed).
IMPORTANT NOTE: To encourage a faster production process of your article, you are requested to closely adhere to the points above for references. Otherwise, it will entail a long process of solving copyeditor’s queries and may directly affect the publication time of your article.
6. Tables. They should be structured properly. Each table must have a clear and concise title.
They should be numbered consecutively in the order in which they appear in the text.
For each Table, there must be a corresponding citation in the text and for each Table citation here must be a corresponding Table.
7. Figures. They should be numbered consecutively in the order in which they appear in the text and must include figure captions. Figures will appear in the published article in the order in which they are numbered initially. The figure resolution should be 300dpi at the time of submission.
8. Appendices. They should be lettered to distinguish from numbered tables and figures. Include a descriptive title for each appendix (e.g., “Appendix A. Variable Names and Definitions”). Cross-check text for accuracy against appendices.
9. Footnotes. Footnotes should be avoided in text, but are allowed on the title page.
IMPORTANT: PERMISSION - The author(s) are responsible for securing permission to reproduce all copyrighted figures or materials before they are published in VES. A copy of the written permission must be included with the manuscript submission.
Papers should only be submitted for consideration once consent is given by all contributing authors. Those submitting papers should carefully check that all those whose work contributed to the paper are acknowledged as contributing authors.
The list of authors should include all those who can legitimately claim authorship. This is all those who:
(i) made a substantial contribution to the concept and design, acquisition of data or analysis and interpretation of data,
(ii) drafted the article or revised it critically for important intellectual content,
(iii) approved the version to be published.
(iv) agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Please refer to the ICMJE Authorship guidelines at http://www.icmje.org/recommendations/browse/roles-and-responsibilities/defining-the-role-of-authors-and-contributors.html
Any acknowledgements should appear first at the end of your article prior to your Declaration of Conflicting Interests (if applicable), any notes and your References.
All contributors who do not meet the criteria for authorship should be listed in an ‘Acknowledgements’ section. Examples of those who might be acknowledged include a person who provided purely technical help, writing assistance, or a department chair who provided only general support. Authors should disclose whether they had any writing assistance and identify the entity that paid for this assistance.
To comply with the guidance for Research Funders, Authors and Publishers issued by the Research Information Network (RIN), VES additionally requires all Authors to acknowledge their funding in a consistent fashion under a separate heading. Please visit Funding Acknowledgements on the SAGE Journal Author Gateway to confirm the format of the acknowledgment text in the event of funding or state in your acknowledgments that: This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.
Declaration of conflicting interests
It is the policy of VES to require a declaration of conflicting interests from all authors enabling a statement to be carried within the paginated pages of all published articles.
Please include any declaration at the end of your manuscript after any acknowledgements and prior to the references, under a heading ‘Conflict of interests’. If no declaration is made the following will be printed under this heading in your article: ‘None declared’. Alternatively, you may wish to state that ‘The Author(s) declare(s) that there is no conflict of interest’.
When making a declaration the disclosure information must be specific and include any financial relationship that all authors of the article has with any sponsoring organization and the for-profit interests the organization represents, and with any for-profit product discussed or implied in the text of the article.
Any commercial or financial involvements that might represent an appearance of a conflict of interest need to be additionally disclosed in the covering letter accompanying your article to assist the Editor in evaluating whether sufficient disclosure has been made within the Declaration of Conflicting Interests provided in the article.
For more information please visit the SAGE Journal Author Gateway.
All papers reporting animal and human studies must include whether written consent was obtained from the local Ethics Committee or Institutional Review Board. Please ensure that you have provided the full name and institution of the review committee and an Ethics Committee reference number.
We accept manuscripts that report human and/or animal studies for publication only if it is made clear that investigations were carried out to a high ethical standard. Studies in humans which might be interpreted as experimental (e.g. controlled trials) should conform to the Declaration of Helsinki http://www.wma.net/en/30publications/10policies/b3/index.html and typescripts must include a statement that the research protocol was approved by the appropriate ethical committee. In line with the Declaration of Helsinki 1975, revised Hong Kong 1989, we encourage authors to register their clinical trials (at http://clinicaltrials.gov or other suitable databases identified by the ICMJE, http://www.icmje.org/publishing_10register.html). If your trial has been registered, please state this on the Title Page. When reporting experiments on animals, indicate on the Title Page which guideline/law on the care and use of laboratory animals was followed.
Authors are required to ensure the following guidelines are followed, as recommended by the International Committee of Medical Journal Editors, Uniform Requirements for Manuscripts Submitted to Biomedical Journals. Patients have a right to privacy that should not be infringed without informed consent. Identifying information, including patients' names, initials, or hospital numbers, should not be published in written descriptions, photographs, and pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian) gives written informed consent for publication. Informed consent for this purpose requires that a patient who is identifiable be shown the manuscript to be published.
Identifying details should be omitted if they are not essential. Complete anonymity is difficult to achieve, however, and informed consent should be obtained if there is any doubt. For example, masking the eye region in photographs of patients is inadequate protection of anonymity. If identifying characteristics are altered to protect anonymity, such as in genetic pedigrees, authors should provide assurance that alterations do not distort scientific meaning and editors should so note. When informed consent has been obtained it should be indicated in the submitted article.
As part of the submission process you will be asked to provide the names of peers who could be called upon to review your manuscript. Recommended reviewers should be experts in their fields and should be able to provide an objective assessment of the manuscript. Please be aware of any conflicts of interest when recommending reviewers. Examples of conflicts of interest include (but are not limited to) the below:
- The reviewer should have no prior knowledge of your submission
- The reviewer should not have recently collaborated with any of the authors
- Reviewer nominees from the same institution as any of the authors are not permitted
Please note that the Editors are not obliged to invite any recommended/opposed reviewers to assess your manuscript.
Contributor’s publishing agreement
Before publication, SAGE requires the author as the rights holder to sign a Journal Contributor’s Publishing Agreement. SAGE’s Journal Contributor’s Publishing Agreement is an exclusive license agreement which means that the author retains copyright in the work but grants SAGE the sole and exclusive right and license to publish for the full legal term of copyright. Exceptions may exist where an assignment of copyright is required or preferred by a proprietor other than SAGE. In this case copyright in the work will be assigned from the author to the society. For more information please visit our Frequently Asked Questions on the SAGE Journal Author Gateway.
VES and SAGE take issues of copyright infringement, plagiarism or other breaches of best practice in publication very seriously. We seek to protect the rights of our authors and we always investigate claims of plagiarism or misuse of articles published in the journal. Equally, we seek to protect the reputation of the journal against malpractice. Submitted articles may be checked using duplication-checking software. Where an article is found to have plagiarized other work or included third-party copyright material without permission or with insufficient acknowledgement, or where authorship of the article is contested, we reserve the right to take action including, but not limited to: publishing an erratum or corrigendum (correction); retracting the article (removing it from the journal); taking up the matter with the head of department or dean of the author’s institution and/or relevant academic bodies or societies; banning the author from publication in the journal or all SAGE journals, or appropriate legal action.
Authors are responsible for obtaining permission from copyright holders for reproducing any illustrations, tables, figures or lengthy quotations previously published elsewhere. For further information including guidance on fair dealing for criticism and review, please visit our Frequently Asked Questions on the SAGE Journal Author Gateway.
As part of our commitment to ensuring an ethical, transparent and fair peer review process SAGE is a supporting member of ORCID, the Open Researcher and Contributor ID. ORCID provides a unique and persistent digital identifier that distinguishes researchers from every other researcher, even those who share the same name, and, through integration in key research workflows such as manuscript and grant submission, supports automated linkages between researchers and their professional activities, ensuring that their work is recognized.
The collection of ORCID iDs from corresponding authors is now part of the submission process of this journal. If you already have an ORCID iD you will be asked to associate that to your submission during the online submission process. We also strongly encourage all co-authors to link their ORCID ID to their accounts in our online peer review platforms. It takes seconds to do: click the link when prompted, sign into your ORCID account and our systems are automatically updated. Your ORCID iD will become part of your accepted publication’s metadata, making your work attributable to you and only you. Your ORCID iD is published with your article so that fellow researchers reading your work can link to your ORCID profile and from there link to your other publications.